Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTULV0X)

DTT Name	Reactive oxygen species (ROS) DTT Info
Gene Name	ROS

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tafenoquine	DM1XT4N	Malaria	1F40-1F45	Approved	[1]
------------------------------------------------------------------------------------

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Mitoquinone	DMKPZ0Q	Hepatitis C virus infection	1E51.1	Phase 2	[2]
Procysteine	DMF9RB4	Amyotrophic lateral sclerosis	8B60.0	Phase 2	[3]
Sodium pyruvate	DMST6A3	Asthma	CA23	Phase 1/2	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Tafenoquine: First Global Approval.Drugs. 2018 Sep;78(14):1517-1523.
2	Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels. Int J Mol Sci. 2020 Aug 27;21(17):6192.
3	Protective effect of procysteine on Acinetobacter pneumonia in hyperoxic conditions. J Antimicrob Chemother. 2013 Oct;68(10):2305-10.
4	A molecular mechanism of pyruvate protection against cytotoxicity of reactive oxygen species in osteoblasts. Mol Pharmacol. 2006 Sep;70(3):925-35.